3537 S I-35 E, Suite 112, Denton Mon–Thu 9:00 a.m. to 4:00 p.m.
Menu

Brighter Minds. Brighter Tomorrows.

Call 940-828-MOVE (6683) Patient Portal
Call 940-828-MOVE (6683)
Jerome Lisk, MD, MBA, MS, FAAN

About Dr. Lisk

Jerome Lisk, MD, MBA, MS, FAAN

A board-certified neurologist, fellowship-trained in movement disorders, who also specializes in memory disorders and dementia. Dr. Lisk has over 20 years of clinical practice experience and cares for patients from Denton and across North Texas.

  • Fellowship trained in movement disorders
  • Clinical Assistant Professor, UNT Health Fort Worth
  • Over 20 years of clinical practice experience

Credentials

  • Fellowship Trained · Movement Disorders

  • Board Certified · American Board of Psychiatry and Neurology

  • Board Certified · National Board of Physicians and Surgeons

  • Fellow · American Academy of Neurology (FAAN)

  • Clinical Assistant Professor · UNT Health Fort Worth

  • Over 20 years of clinical practice experience

Jerome Lisk, M.D., MBA, MS, FAAN

  • Fellowship Trained in Movement Disorders
  • Board Certified National Board of Physicians and Surgeons
  • Board Certified American Board of Psychiatry and Neurology
  • Active medical licenses in California, Missouri, and Texas
  • Clinical Assistant Professor, UNT Health Fort Worth (University of North Texas Health Science Center)
  • NFL Appeals Advisory Panel Member
  • Board of Directors, Texas Health Services Authority

Training

  1. Medical school (MD)Medical College of Virginia
  2. InternshipCharles Drew/UCLA Medical Center
  3. Neurology residencyUniversity of Texas at Houston
  4. Movement disorders fellowshipUniversity of Texas at Houston
  5. MBA, Healthcare ManagementNaveen Jindal School of Management, The University of Texas at Dallas; summa cum laude, Beta Gamma Sigma International Business Honor Society
  6. In practiceOver 20 years of clinical practice experience

National expertise

  • Invited national lecturer on Parkinson’s disease and tardive dyskinesia, speaking to physicians across the United States.

  • Member, NFL Appeals Advisory Panel, providing expertise in Parkinson’s disease, Alzheimer’s disease, and cognitive impairment.

  • Radio host for ReachMD, hosting NeuroFrontiers conversations with experts on the latest in neurology. Listen to his episodes.

  • Experienced educator and public speaker who has presented at American Academy of Neurology annual meetings and on multiple television, radio, and podcast programs. See his media appearances.

  • Board of Directors, Texas Health Services Authority, promoting secure health information exchange to improve patient care, and helping develop the PULSE emergency system.

  • Senior medical advisor since 2015 to several biotechnology companies, including medical device and nuclear medicine imaging companies.

  • Has served as an independent consultant, digital opinion leader, and key opinion leader for pharmaceutical companies.

Research

Phase 3 trial, Movement Disorders 2015

Co-author of the Phase 3 trial that supported FDA approval of Northera (droxidopa) for neurogenic orthostatic hypotension in Parkinson’s disease.

Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Movement Disorders 2015;30:646-654.

  • Principal investigator in numerous clinical trials in Parkinson’s disease, including pivotal studies that contributed to the approval of droxidopa (Northera) for treating neurogenic orthostatic hypotension

  • Sub-investigator, Parkinson’s disease research with B. Rhett Rigby, PhD, School of Health Promotion and Kinesiology, Texas Woman’s University

  • Sub-investigator, clinical research, TriCelX

  • Research collaboration with Michael Salvatore, PhD, and Vicki Nejtek, PhD, UNT Health Fort Worth

In the community

Dr. Lisk co-founded the Dallas Area Parkinson Society’s Parkinson’s disease support group at the Denton Senior Center.

In 2013, Dr. Lisk founded Parkinson’s Awareness Day in the City of San Marino, California. The city proclaimed May 4 as Parkinson’s Awareness Day, approved by Mayor Richard Ward.

Support groups and patient resources

Affiliations

  • UNT Health Fort Worth
  • Texas Woman’s University
  • TriCelX

Publications

  1. 2026
    Cardiovascular Dysautonomia and Sudden Cardiac Death in Parkinson’s Disease: Emerging Clinical Insights and Implications for Care. Fisher K, Haji S, Rudmann E, Danisi F, Lisk J, Ravikumar V, Frishman W, Hirani R, Etienne M. Cardiology in Review. 2026.
  2. 2026
    Cardiovascular Safety of Parkinson’s Disease Therapies: A Comprehensive Review. Qian B, Munjal R, Haselkorn R, Mckay L, Lu K, Hirani R, Lisk JP, Karp A, Ravikumar V, Frishman WH, Etienne M. Cardiology in Review. 2026.
  3. 2025
    Eye movements during the Iowa Gambling Task in Parkinson’s disease: a brief report. Doshier K, Ryals AJ, Nejtek VA, Salvatore MF, Lisk J. Frontiers in Psychology. 2025.
  4. 2024
    Moderate intensity aerobic exercise alleviates motor deficits in 6-OHDA lesioned rats and reduces serum levels of biomarkers of Parkinson’s disease severity without recovery of striatal dopamine or tyrosine hydroxylase. Kasanga EA, Soto I, Centner A, McManus R, Shifflet MK, Navarrete W, Han Y, Lisk J, Ehrhardt T, Wheeler K, Mhatre-Winters I, Richardson JR, Bishop C, Nejtek VA, Salvatore MF. Experimental Neurology. 2024.
  5. 2024
    The Whole Physician: Ten Action Items to Combat Peer-to-Peer and Institutional Racial Bias in Medicine. Lisk J, Mathew PG, Ali N, Charleston L IV, Spears RC, Armand CE, Farheen A, Moon JS, Burrus TM. Practical Neurology. 2024.
  6. 2019
    Engaging Older Adults With Parkinson’s Disease in Physical Activity Using Technology: A Feasibility Study. Hermanns M, Haas BK, Lisk J. Gerontology & Geriatric Medicine. 2019.
  7. 2015

Links open the PubMed record at the U.S. National Library of Medicine, or the journal’s article page.

Schedule a visit

Call 940-828-MOVE (6683) Patient Portal
Call 940-828-6683